Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Awan FT"'
Autor:
Susan O'Brien, Paolo Ghia, William G. Wierda, S Devereux, Jennifer A. Woyach, Raquel Izumi, Jennifer R. Brown, Wayne Rothbaum, Ahmed Hamdy, Jesse McGreivy, Richard R. Furman, Jacqueline C. Barrientos, Amy J. Johnson, John M. Pagel, Thomas G. Diacovo, Xiaolin Wang, Jorge M. Chaves, Deborah M. Stephens, Maria Fardis, Allard Kaptein, Brian J. Lannutti, Dave Johnson, Bonnie K. Harrington, John C. Byrd, Jeffrey A. Jones, Farrukh T. Awan, Todd Covey, Jane Huang, Peter Hillmen, Anna Schuh
Publikováno v:
The New England journal of medicine, vol 374, iss 4
Background Irreversible inhibition of Bruton's tyrosine kinase (BTK) by ibrutinib represents an important therapeutic advance for the treatment of chronic lymphocytic leukemia (CLL). However, ibrutinib also irreversibly inhibits alternative kinase ta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1872ec7bfbf0bb4cdaab7a369930ddfa
https://pubmed.ncbi.nlm.nih.gov/27248633
https://pubmed.ncbi.nlm.nih.gov/27248633
Autor:
Pophali PA; Division of Hematology, Medical Oncology and Palliative Care, University of Wisconsin, Carbone Cancer Center, Madison, WI., Fein JA; Division of Hematology and Oncology, Weill Cornell Medicine, New York, NY., Ahn KW; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI., Allbee-Johnson M; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI., Ahmed N; Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center, Kansas City, KS., Awan FT; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX., Farhan S; Henry Ford Health System Stem Cell Transplant & Cellular Therapy Program, Detroit, MI., Grover NS; Division of Hematology, University of North Carolina, Chapel Hill, NC., Hilal T; Division of Hematology and Oncology, Mayo Clinic, Phoenix, AZ., Iqbal M; Division of Hematology/Oncology, Mayo Clinic, Jacksonville, FL., Maakaron J; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN., Modi D; Karmanos Cancer Institute, Wayne State University, Detroit, MI., Nasrollahi E; Department of Internal Medicine, University of Pittsburgh Medical Center in Central Pa., Harrisburg, PA., Schachter LG; University of California Los Angeles, Los Angeles, CA., Sauter C; Department of Hematology and Medical Oncology, Blood and Marrow Transplant Program, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH., Hamadani M; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI.; Department of Medicine, Blood and Marrow Transplant and Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, WI., Herrera A; Division of Lymphoma, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA., Shouval R; Department of Medicine, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY., Shadman M; Fred Hutchinson Cancer Center and University of Washington, Seattle, WA.
Publikováno v:
Blood advances [Blood Adv] 2024 Oct 22; Vol. 8 (20), pp. 5290-5296.
Autor:
Premnath N; Division of Hematology, Oncology and Transplantation, University of Minnesota, Masonic Cancer Center, Minneapolis, MN., Liu Y; Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX., Reves H; Section of Hematologic Malignancies and Cellular Therapy, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX., Pandey U; Section of Hematologic Malignancies and Cellular Therapy, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX., Nair RG; Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX., Anderson J; Section of Hematologic Malignancies and Cellular Therapy, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX., Afrough A; Section of Hematologic Malignancies and Cellular Therapy, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX., Anderson LD Jr; Section of Hematologic Malignancies and Cellular Therapy, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX., Chung SS; Section of Hematologic Malignancies and Cellular Therapy, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX., Kaur G; Section of Hematologic Malignancies and Cellular Therapy, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX., Khan AM; Section of Hematologic Malignancies and Cellular Therapy, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX., Kumar KA; Department of Radiation Oncology, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX., Madanat YF; Section of Hematologic Malignancies and Cellular Therapy, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX., Wolfe HR; Section of Hematologic Malignancies and Cellular Therapy, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX., Yilmaz E; Section of Hematologic Malignancies and Cellular Therapy, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX., Awan FT; Section of Hematologic Malignancies and Cellular Therapy, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX., Sweetenham J; Section of Hematologic Malignancies and Cellular Therapy, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX., Ramakrishnan Geethakumari P; Section of Hematologic Malignancies and Cellular Therapy, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX.
Publikováno v:
JCO oncology practice [JCO Oncol Pract] 2024 Oct 17, pp. OP2400354. Date of Electronic Publication: 2024 Oct 17.
CAR T-cell therapy in mantle cell lymphoma with secondary CNS involvement: a multicenter experience.
Autor:
Ahmed G; Division of Hematology-Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI., Alsouqi A; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA., Szabo A; Division of Hematology-Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI., Samples L; Division of Hematology-Oncology, Department of Medicine, Fred Hutchinson Cancer Center, Seattle, WA., Shadman M; Division of Hematology-Oncology, Department of Medicine, Fred Hutchinson Cancer Center, Seattle, WA., Awan FT; Division of Hematology-Oncology, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, TX., Rojek AE; David and Etta Jonas Center for Cellular Therapy, The University of Chicago, Chicago, IL., Riedell PA; David and Etta Jonas Center for Cellular Therapy, The University of Chicago, Chicago, IL., Iqbal M; Division of Hematology-Oncology, Department of Medicine, Mayo Clinic Florida, Jacksonville, FL., Fenske TS; Division of Hematology-Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI., Kharfan-Dabaja MA; Division of Hematology-Oncology, Department of Medicine, Mayo Clinic Florida, Jacksonville, FL., Ito S; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA., Hamadani M; Division of Hematology-Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.
Publikováno v:
Blood advances [Blood Adv] 2024 Jul 09; Vol. 8 (13), pp. 3528-3531.
Autor:
Iqbal M; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USA. Iqbal.Madiha@Mayo.Edu., Jagadeesh D; Cleveland Clinic, Cleveland, OH, USA., Chavez J; Moffitt Cancer Center, Tampa, FL, USA., Khurana A; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Rosenthal A; Division of Hematology and Oncology, Mayo Clinic, Phoenix, AZ, USA., Craver E; Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL, USA., Epperla N; Arthur G. James Cancer Hospital & Richard J. Solove Research Institute, The Ohio State University, Columbus, OH, USA., Li Z; Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL, USA., Isufi I; Yale School of Medicine and Yale Cancer Center, New Haven, CT, USA., Awan FT; Harold C. Simmons Comprehensive Cancer Center and University of Texas Southwestern Medical Center, Dallas, TX, USA., Dholaria BR; Vanderbilt- Ingram Cancer Center and Vanderbilt University Medical center, Nashville, TN, USA., Maakaron JE; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA., Sandoval-Sus JD; Moffitt Cancer Center at Memorial Healthcare System, Pembroke Pines, FL, USA., Mishra R; Cleveland Clinic, Cleveland, OH, USA., Saha A; Moffitt Cancer Center, Tampa, FL, USA., Annunzio K; Arthur G. James Cancer Hospital & Richard J. Solove Research Institute, The Ohio State University, Columbus, OH, USA., Bhaskar ST; Vanderbilt- Ingram Cancer Center and Vanderbilt University Medical center, Nashville, TN, USA., Sumransub N; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA., Fijalka A; Department of Pharmacy-M Health Fairview University of Minnesota Medical Center, Minneapolis, MN, USA., Ivanov SA; Moffitt Cancer Center at Memorial Healthcare System, Pembroke Pines, FL, USA., Lin Y; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Kharfan-Dabaja MA; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USA.
Publikováno v:
Bone marrow transplantation [Bone Marrow Transplant] 2024 Feb; Vol. 59 (2), pp. 211-216. Date of Electronic Publication: 2023 Nov 16.
Autor:
Arshad S; School of Medicine, University of Kentucky, Lexington, KY, USA., Fang X; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI, USA., Ahn KW; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI, USA., Kaur M; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA., Scordo M; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sauter CS; Cleveland Clinic Foundation, Cleveland, OH, USA., Furqan F; Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA., Awan FT; Division of Hematology and Oncology, UT Southwestern, Dallas, TX, USA., Hamadani M; Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA. mhamadani@mcw.edu.
Publikováno v:
Bone marrow transplantation [Bone Marrow Transplant] 2023 Nov; Vol. 58 (11), pp. 1203-1208. Date of Electronic Publication: 2023 Aug 10.
Autor:
Quartermaine C; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio, USA., Ghazi SM; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio, USA., Yasin A; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio, USA., Awan FT; Division of Hematology, UT-Southwestern Medical Center, Dallas, Texas, USA., Fradley M; Cardio-Oncology Program, Division of Cardiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Wiczer T; Department of Pharmacy, James Cancer Hospital and Solove Research Institute, Columbus, Ohio, USA., Kalathoor S; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio, USA., Ferdousi M; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio, USA., Krishan S; Department of Medicine, University of Oklahoma Medical Center, Oklahoma City, Oklahoma, USA., Habib A; Division of Hematology, The Ohio State University, Columbus, Ohio, USA., Shaaban A; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio, USA., Kola-Kehinde O; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio, USA., Kittai AS; Division of Hematology, The Ohio State University, Columbus, Ohio, USA., Rogers KA; Division of Hematology, The Ohio State University, Columbus, Ohio, USA., Grever M; Division of Hematology, The Ohio State University, Columbus, Ohio, USA., Ruz P; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio, USA., Bhat S; Division of Hematology, The Ohio State University, Columbus, Ohio, USA., Dickerson T; Department of Pharmacy, James Cancer Hospital and Solove Research Institute, Columbus, Ohio, USA., Byrd JC; Department of Medicine, University of Cincinnati, Cincinnati, Ohio, USA., Woyach J; Division of Hematology, The Ohio State University, Columbus, Ohio, USA., Addison D; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio, USA.; Division of Cancer Prevention and Control, The Ohio State University, Columbus, Ohio, USA.
Publikováno v:
JACC. CardioOncology [JACC CardioOncol] 2023 Oct 17; Vol. 5 (5), pp. 570-590. Date of Electronic Publication: 2023 Oct 17 (Print Publication: 2023).
Autor:
Epperla N; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Kumar A; Department of Internal Medicine, Office of Research, Morsani College of Medicine, University of South Florida, Tampa, Florida., Abutalib SA; Co-Director, Hematology & BMT/Cellular Therapy, Medical Director, NMDP Apheresis Midwest Program Associate Professor, Rosalind Franklin University of Medicine and Science, City of Hope, Zion, Illinois., Awan FT; Division of Hematology and Oncology, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas., Chen YB; Hematopoietic Cell Transplant & Cell Therapy Program, Massachusetts General Hospital, Boston, Massachusetts., Gopal AK; University of Washington/Fred Hutch Cancer Center, Seattle, Washington., Holter-Chakrabarty J; Stephenson Cancer Center, University of Oklahoma, Oklahoma City, Oklahoma., Kekre N; Transplantation & Cellular Therapy Program, University of Ottawa, Ottawa, Ontario, Canada., Lee CJ; Transplant and Cellular Therapy Program at Huntsman Cancer Institute, Salt Lake City, Utah., Lekakis L; University of Miami, Miami, Florida., Lin Y; Mayo Clinic, Rochester, Minnesota., Mei M; City of Hope, Duarte, California., Nathan S; Division of Hematology, Oncology and Cell Therapy, Rush University Medical Center, Chicago, Illinois., Nastoupil L; University of Texas, MD Anderson Cancer Center, Houston, Texas., Oluwole O; Division of Hematology/Oncology, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee., Phillips AA; Division of Hematology and Oncology, Weill Cornell Medicine, New York, New York., Reid E; Moores Cancer Center at UC San Diego Health, La Jolla, California., Rezvani AR; Division of Blood & Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, California., Trotman J; Concord Repatriation General Hospital, University of Sydney, Sydney, Australia., Zurko J; University of Wisconsin, Madison, Wisconsin., Kharfan-Dabaja MA; Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy, Mayo Clinic, Jacksonville, Florida., Sauter CS; Division of Hematology and Oncology, Cleveland Clinic, Cleveland, Ohio., Perales MA; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York., Locke FL; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida., Carpenter PA; University of Washington/Fred Hutch Cancer Center, Seattle, Washington., Hamadani M; BMT & Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, Wisconsin. Electronic address: mhamadani@mcw.edu.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2023 Sep; Vol. 29 (9), pp. 548-555. Date of Electronic Publication: 2023 Jul 05.
Autor:
Sottero T; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA., Awan FT; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Publikováno v:
Hematology/oncology and stem cell therapy [Hematol Oncol Stem Cell Ther] 2023 May 23; Vol. 16 (4), pp. 342-345. Date of Electronic Publication: 2023 May 23.
Autor:
Buck B; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus., Chum AP; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus., Patel M; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus., Carter R; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus.; Center for the Advancement of Team Science, Analytics, and Systems Thinking (CATALYST), Ohio State University College of Medicine, Columbus., Nawaz H; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus.; Division of Cardiology, Northwestern Feinberg School of Medicine, Chicago, Illinois., Yildiz V; Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University, Columbus., Ruz P; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus., Wiczer T; Department of Pharmacy, James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus., Rogers KA; Division of Hematology, James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus., Awan FT; Division of Hematology, James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus.; Division of Hematology/Oncology, University of Texas-Southwestern Medical Center, Dallas., Bhat S; Division of Hematology, James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus., Guha A; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus.; Harrington Heart and Vascular Institute, Case Western Reserve University, Cleveland, Ohio., Kittai AS; Division of Hematology, James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus., Simonetti OP; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus.; Department of Biomedical Engineering, The Ohio State University, Columbus., Raman SV; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus.; Division of Cardiology, Indiana University School of Medicine, Indianapolis., Wallace G; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus., Sanchez R; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus., Bonsu JM; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus., Gambril J; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus., Haddad D; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus., Mann J; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus.; Division of Cardiology, University of Colorado Anschutz Medical Campus, Aurora., Wei L; Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University, Columbus., Kola-Kehinde O; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus., Byrd JC; Division of Hematology, James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus., Woyach JA; Division of Hematology, James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus., Addison D; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus.; Division of Cancer Prevention and Control, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus.
Publikováno v:
JAMA oncology [JAMA Oncol] 2023 Apr 01; Vol. 9 (4), pp. 552-555.